Interferon Therapy Exacerbated Pulmonary Hypertension in a Patient with Hepatitis C Virus Infection: Pathogenic Interplay among Multiple Risk Factors

Pulmonary arterial hypertension (PAH) is known to develop as a consequence of multiple genetic and/or non-genetic factors. A 27-year-old woman with chronic hepatitis C virus (HCV) infection developed severe PAH after interferon (IFN) therapy. Although most of the reported clinical courses of IFN-ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuchiya, Hiromi, Kioka, Hidetaka, Ozu, Kentaro, Ohtani, Tomohito, Yamaguchi, Osamu, Yazaki, Yoshikazu, Yamauchi-Takihara, Keiko, Sakata, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478568/
https://www.ncbi.nlm.nih.gov/pubmed/28458313
http://dx.doi.org/10.2169/internalmedicine.56.7822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478568/
https://www.ncbi.nlm.nih.gov/pubmed/28458313
http://dx.doi.org/10.2169/internalmedicine.56.7822

Ejemplares similares